Bruker Corporation (NASDAQ: BRKR) delivered a sharp earnings beat this morning, lifting shares nearly 7% despite underlying ...

The London Company, an investment management company, released “The London Company Large Cap Strategy” third-quarter 2025 ...

Q3 2025 Earnings Call Transcript November 3, 2025 Bruker Corporation beats earnings expectations. Reported EPS is $0.6, ...

Bruker’s stock price target has recently seen a slight uptick, with consensus analyst forecasts rising from $46.73 to $47.82. This modest increase signals renewed analyst confidence in the company’s ...

With roots dating back to the pioneering days of nuclear magnetic resonance technology, Bruker (NASDAQ:BRKR) develops and ...

Despite a dip in revenue and earnings, Bruker Corp (BRKR) focuses on innovation and cost-saving measures to drive future ...

Analysts are estimating that Bruker will report an earnings per share (EPS) of $0.33. Bruker bulls will hope to hear the ...

Bruker’s MALDI Biotyper CA System wins FDA clearance for new software, faster workflows and 549 validated species.

NYSBC has placed an order for the first Multifield NMR Relaxometry System in North America. In contrast, NSF funding has been ...

Investors in Bruker Corporation BRKR need to pay close attention to the stock based on moves in the options market lately.

Bruker’s stock declined as the company lowered its full-year 2025 guidance, now expecting adjusted EPS of $1.85 to $1.90, below the analyst consensus of $1.94. The company projects annual revenue ...

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools, for ...